Moderna, Inc. (MRNA)
200.10
-2.53
(-1.25%)
USD |
NASDAQ |
Oct 23, 16:00
201.23
+1.13
(+0.56%)
After-Hours: 20:00
Moderna Shareholders Equity (Quarterly) : 6.761B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.761B |
| March 31, 2026 | 7.408B |
| December 31, 2025 | 8.65B |
| September 30, 2025 | 9.33B |
| June 30, 2025 | 9.399B |
| March 31, 2025 | 10.07B |
| December 31, 2024 | 10.90B |
| September 30, 2024 | 11.93B |
| June 30, 2024 | 11.71B |
| March 31, 2024 | 12.82B |
| December 31, 2023 | 13.85B |
| September 30, 2023 | 13.46B |
| June 30, 2023 | 16.95B |
| March 31, 2023 | 18.86B |
| December 31, 2022 | 19.12B |
| September 30, 2022 | 17.99B |
| June 30, 2022 | 17.98B |
| March 31, 2022 | 17.08B |
| Date | Value |
|---|---|
| December 31, 2021 | 14.14B |
| September 30, 2021 | 10.12B |
| June 30, 2021 | 6.704B |
| March 31, 2021 | 3.838B |
| December 31, 2020 | 2.561B |
| September 30, 2020 | 2.760B |
| June 30, 2020 | 2.947B |
| March 31, 2020 | 1.641B |
| December 31, 2019 | 1.175B |
| September 30, 2019 | 1.252B |
| June 30, 2019 | 1.339B |
| March 31, 2019 | 1.446B |
| December 31, 2018 | 1.530B |
| September 30, 2018 | 1.076B |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 625.30M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.606B |
| Vaxcyte, Inc. | 2.758B |
| Twist Bioscience Corp. | 445.74M |
| BioNTech SE | 20.30B |
| Vir Biotechnology, Inc. | 982.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.96B |
| Total Liabilities (Quarterly) | 4.20B |
| Debt to Equity Ratio | 0.1904 |
| Current Ratio | 2.295 |
| Net Debt Paydown Yield | -0.39% |